bpc 157 alone or with tb500 Revolutionizing Recovery: How Dr. Lundquist is Using BPC-157, TB-500, and Regenerative Therapies to Accelerate Healing 💉PEPTIDES💉 Everyone's hyped about peptides

Key findings from this body of work include: AOD-9604 stimulated proteoglycan synthesis in bovine cartilage explants in a dose-dependent manner The peptide promoted the differentiation of mesenchymal stem cells toward the chondrocyte lineage In a rabbit model of osteoarthritis, intra-articular injection of AOD-9604 was associated with improved cartilage scores and reduced degradation markers compared to controls The effects were observed without the IGF-1 elevation or metabolic side effects associated with full-length growth hormone Clinical Observations Physicians prescribing AOD-9604 in clinical peptide therapy settings have reported improvements in joint comfort and function among their patients

His office is quick to accommodate appointments, where many times it is next day if need be, this is rare to find with most doctors offices

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)

The important caveat is that Retatrutide remains in Phase 3 trials and has not yet received prescription approval in Canada or the US